ETFChannel.com
ABBV Description — AbbVie Inc

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.

Company Name: 
AbbVie Inc
Website: 
www.abbvie.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding ABBV: 
130
Total Market Value Held by ETFs: 
$32,815,131,759.06
Total Market Capitalization: 
$272,382,000,000
% of Market Cap. Held by ETFs: 
12.05%
 ETF   ABBV Weight   ABBV Amount 
 VTI   0.68%   $7,937,762,968         
 VOO   0.87%   $5,898,766,138         
 SPY   0.85%   $2,937,625,897         
 IVV   0.85%   $2,354,272,493         
 VTV   1.66%   $2,298,808,301         
 XLV   5.55%   $2,082,360,334         
 VYM   2.00%   $1,085,477,120         
 VHT   4.81%   $877,660,534         
 IWF   1.53%   $873,840,360         
 HDV   5.81%   $733,712,092         
List of all 130 ETFs holding ABBV »
Quotes delayed 20 minutes

Email EnvelopeFree ABBV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (3.03 out of 4)
22nd percentile
(ranked lower than approx. 78% of all stocks covered)

Analysts Forecast:
ABBV Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding ABBV | AbbVie Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.